NEXI
Income statement / Annual
Last year (2023), NexImmune, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, NexImmune, Inc.'s net income was -$32.34 M.
See NexImmune, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.02 M |
$1.50 M |
$870,285.00 |
$618,990.00 |
$436,365.00 |
$204,646.00 |
| Gross Profit |
-$1.02 M |
-$1.50 M |
-$870,285.00 |
-$618,990.00 |
-$436,365.00 |
-$204,646.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$18.26 M
|
$47.15 M
|
$37.46 M
|
$17.84 M
|
$15.17 M
|
$8.00 M
|
| General & Administrative
Expenses |
$13.00 B
|
$15.93 M
|
$15.80 M
|
$10.01 M
|
$5.71 M
|
$5.24 M
|
| Selling & Marketing
Expenses |
-$12.99 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.91 M
|
$15.93 M
|
$15.80 M
|
$10.01 M
|
$5.71 M
|
$5.24 M
|
| Other Expenses |
$0.00 |
-$87,682.00 |
-$61,407.00 |
$89,777.00 |
$92,278.00 |
$136,788.00 |
| Operating Expenses |
$28.17 M |
$63.08 M |
$53.26 M |
$27.85 M |
$20.89 M |
$13.24 M |
| Cost And Expenses |
$29.19 M |
$63.08 M |
$53.26 M |
$27.85 M |
$20.89 M |
$13.24 M |
| Interest Income |
$698.40 M |
$664,372.00 |
$52,511.00 |
$20,837.00 |
$246,780.00 |
$272,436.00 |
| Interest Expense |
$0.00 |
$0.00 |
$905,326.00 |
$1.68 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.02 M
|
$1.50 M
|
$870,285.00
|
$618,990.00
|
$436,365.00
|
$204,646.00
|
| EBITDA |
-$28.17 M
|
-$61.59 M
|
-$52.39 M
|
-$27.12 M
|
-$20.45 M
|
-$13.04 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$3.15 M
|
$576,691.00
|
$2.35 M
|
-$2.01 M
|
$339,058.00
|
$409,224.00
|
| Income Before Tax |
-$32.34 M |
-$62.51 M |
-$50.90 M |
-$29.87 M |
-$20.55 M |
-$12.83 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$2.00 |
-$576.69 M |
$843,919.00 |
$1.77 M |
-$246,780.00 |
$409,224.00 |
| Net Income |
-$32.34 M |
$514.18 M |
-$51.75 M |
-$31.64 M |
-$20.30 M |
-$12.83 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-30.82 |
534.29 |
-56.67 |
-34.76 |
-22.53 |
-14.25 |
| EPS Diluted |
-30.82 |
534.29 |
-56.67 |
-34.76 |
-22.53 |
-14.25 |
| Weighted Average Shares
Out |
$1.05 M
|
$962,364.00
|
$913,156.00
|
$910,311.00
|
$900,861.00
|
$900,861.00
|
| Weighted Average Shares
Out Diluted |
$1.05 M
|
$962,364.00
|
$913,156.00
|
$910,311.00
|
$900,861.00
|
$900,861.00
|
| Link |
|
|
|
|
|
|
